China’s Wuhan Institute Files to Patent the Use of Gilead’s Remdesivir for Coronavirus | BioSpace
The Wuhan Institute of Virology, part of the China Academy of Sciences, has applied to patent the use of Gilead Sciences’ remdesivir to treat the current coronavirus outbreak.